Head & Neck Cancer Is Still Found Too Late — And OrisDX Is Changing That
In this episode of Diagnosing Dx, I’m joined by Harald Steltzer, CEO of OrisDX, a company tackling one of the most overlooked gaps in diagnostics: early detection of head and neck cancer. Harald shares his journey from biochemistry and genetics into startup leadership, and why dentistry may be one of the most overlooked frontlines for early cancer detection today. We explore how OrisDX is rethinking diagnostics to reduce clinical friction, improve patient outcomes, and tackle one of healthcare’s hardest problems: reimbursement and adoption. This episode is a focused deep dive into…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.